Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the ...

We recently published 10 Stocks Crushing While Wall Street Naps. Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the top ...

IQV currently has a forward P/E ratio of 17.82, while CLBT has a forward P/E of 51.84. We also note that IQV has a PEG ratio of 1.53. This popular figure is similar to the widely-used P/E ratio ...

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

Investors in Cellebrite DI Ltd (Symbol: CLBT) saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

We came across a bullish thesis on Cellebrite DI Ltd. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on CLBT. Cellebrite DI Ltd.’s share was trading at $13.98 as ...

CLBT trades at 4X EV/CY 24 ARR (annual recurring revenue), a significant discount to a peer group average of more than 7x. Like PAR, we have the opportunity for revenue growth, earnings growth ...

Cellebrite DI Ltd. Annual stock financials by MarketWatch. View the latest CLBT financial statements, income statements and financial ratios.

Cellebrite DI Ltd. (CLBT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

For comparison, CLBT has a P/B of 34.06. These metrics, and several others, help IQV earn a Value grade of B, while CLBT has been given a Value grade of C.